Lipocine Regulatory Wednesday, October 7, 2026 +0.50 Positive

Lipocine partner Verity Pharma获Health Canada批准TLANDO

Lipocine及其合作伙伴Verity Pharma宣布,Health Canada已批准TLANDO用于加拿大男性睾丸激素缺乏症治疗,Verity Pharma计划于2026年底前启动商业化。

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed